- Home
- AIBZ vs STRO Comparison
AIBZ vs STRO Comparison
Compare AIBZ & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIBZ | STRO |
|---|---|---|
| Founded | N/A | 2003 |
| Country | Canada | United States |
| Employees | N/A | 133 |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.2M | 381.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AIBZ | STRO |
|---|---|---|
| Price | $5.24 | $23.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $31.33 |
| AVG Volume (30 Days) | ★ 619.9K | 329.1K |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.87 | $0.72 |
| 52 Week High | $9.91 | $43.85 |
Technical Indicators
Market Signals| Indicator | AIBZ | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 30.73 | 37.09 |
| Support Level | N/A | $19.11 |
| Resistance Level | $8.33 | $27.96 |
| Average True Range (ATR) | 0.64 | 1.67 |
| MACD | -0.18 | -0.21 |
| Stochastic Oscillator | 11.19 | 18.31 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.